Safety and efficacy of Philips’ Stellarex .035 low-dose drug-coated balloon demonstrated in clinical trials at three years
May 29, 2019 Amsterdam, the Netherlands and New Orleans, U.S. – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader ...
Read moreDetails
